Real-time enrollment status for this retroperitoneal sarcoma clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 8:58 PM UTC
| NCT Number | NCT01659203 |
| Recruiting Status | Recruiting |
| Condition | Retroperitoneal Sarcoma |
| Phase | PHASE1 |
| Target Enrollment | 80 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | July 31, 2026 (3 weeks ago) |
As of August 27, 2026: Clinical trial NCT01659203 is currently recruiting participants. This phase1 study for retroperitoneal sarcoma is actively seeking new participants at 10 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01659203 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01659203 was last updated 3 weeks ago (July 31, 2026). HelloStudys verifies this status automatically.